✦ LIBER ✦

Prognostic Assessment of Polymorphisms of the MDR-1 and GSTP1 Genes in Patients with Stage II and III Breast Cancer Submitted to Neoadjuvant Chemotherapy

✍ Scribed by Fábio Francisco Oliveira Rodrigues; Roberto Euzébio dos Santos; André Lima de Oliveira; Renato de Lima Rozenowicz; Mônica Barbosa de Melo; Daniel Kashiwamura Scheffer

Book ID: 109080284
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 49 KB
Volume: 18
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1524-4741.2011.01211.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Distribution of TYMS, MTHFR, p53 and MDR

Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy

✍ Luis Alberto Henríquez-Hernández; Adolfo Murias-Rosales; Ana González-Hernández; 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 121 KB

FDG PET evaluation of early axillary lym

FDG PET evaluation of early axillary lymph node response to neoadjuvant chemotherapy in stage II and III breast cancer patients

✍ Caroline Rousseau; Anne Devillers; Mario Campone; Loïc Campion; Ludovic Ferrer; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 250 KB

The Role of Serum CEA as a Prognostic In

The Role of Serum CEA as a Prognostic Indicator in Stage II and III Breast Cancer Patients Treated With Adjuvant Chemotherapy

✍ Richard L. Theriault; Gabriel N. Hortobagyi; Herbert A. Fritsche; Debbie Frye; R 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Prognostic significance of the detection

Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy

✍ Patriarca, F; Sacco, C; Sperotto, A; Geromin, A; Damiani, D; Fili, C; Cerno, M; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Quality of life among patients with Stag

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy : Results from Cancer and Leukemia Group B 9066

✍ Jeffrey Peppercorn; James Herndon II; Alice B. Kornblith; William Peters; Tim Ah 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to compare the quality of life (QOL) after treatment among patients who had breast carcinoma with multiple positive lymph nodes. The patients were randomized to receive either high‐dose chemotherapy with autologous stem cell support (HDC) o

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views